St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

The study found that early intervention led to an 80% reduction in heart failure hospitalisations one year after treatment.

Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.

EW's new late-breaking clinical data shows early intervention in AS may slash significant costs and improve patient outcomes.